Chemocentryx (CCXI) Narrows Q3 Loss to 28c/Share

Chemocentryx (NASDAQ: CCXI) reported Q3 EPS of ($0.28), versus ($2.06) reported last year. Revenue for the quarter came in at $1.13 million, versus $1.44 million reported last year.

For earnings history and earnings-related data on Chemocentryx (CCXI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Activist investors push Seer, Inc. to disclose go-private timeline
• Axos Financial (AX) PT Raised to $120 at Benchmark